Gamida Cell Ltd.
NASDAQ:GMDA
0.0327 (USD) • At close April 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|
Revenue
| 1.784 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue
| 3.478 | 0.44 | 0.431 | 0.357 | 2.143 | 0 | 0 | 0 |
Gross Profit
| -1.694 | -0.44 | -0.431 | -0.357 | -2.143 | 0 | 0 | 0 |
Gross Profit Ratio
| -0.95 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Reseach & Development Expenses
| 22.284 | 42.692 | 50.177 | 41.385 | 31.462 | 22.045 | 15.018 | 19.095 |
General & Administrative Expenses
| 44.584 | 19.401 | 16.977 | 12.167 | 12.091 | 11.599 | 4.472 | 4.614 |
Selling & Marketing Expenses
| 4.081 | 0.013 | 0.02 | 0.009 | 0.005 | 0 | 0 | 0 |
SG&A
| 48.665 | 19.401 | 16.977 | 12.167 | 12.091 | 11.599 | 4.472 | 4.614 |
Other Expenses
| -0.395 | 12.9 | 20.013 | 8.748 | 4.692 | 0.195 | -2.265 | 1.812 |
Operating Expenses
| 70.949 | 74.993 | 87.167 | 62.3 | 48.245 | 33.644 | 19.49 | 23.709 |
Operating Income
| -72.643 | 74.993 | -87.167 | -62.3 | -48.245 | -33.644 | -19.49 | -23.709 |
Operating Income Ratio
| -40.719 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Other Income Expenses Net
| 9.647 | -154.368 | -2.626 | -10.404 | 13.824 | -17.989 | 0.834 | 0.898 |
Income Before Tax
| -62.996 | -79.375 | -89.793 | -72.704 | -34.421 | -52.861 | -19.011 | -22.671 |
Income Before Tax Ratio
| -35.312 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Tax Expense
| -0 | 74.993 | 2.626 | 3.744 | -0.07 | 0.07 | -0.479 | -1.038 |
Net Income
| -62.996 | -154.368 | -92.419 | -76.448 | -34.351 | -52.931 | -19.011 | -22.671 |
Net Income Ratio
| -35.312 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS
| -0.57 | -2.42 | -1.56 | -1.75 | -1.17 | -10.53 | -1.06 | -1.26 |
EPS Diluted
| -0.57 | -2.42 | -1.56 | -1.75 | -1.16 | -10.53 | -1.06 | -1.26 |
EBITDA
| -70.619 | -74.553 | -86.736 | -59.667 | -28.953 | -32.602 | -20.162 | -24.483 |
EBITDA Ratio
| -39.585 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |